
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
TOC
over 21 years ago
Pharm Exec Ad Starsover 21 years ago
Elephant or Specialist?over 21 years ago
Global Report: Iron Fistover 21 years ago
Washington Report: The Pendulum Swingsover 21 years ago
What Does It Take to be a Global Leader in Trainingover 21 years ago
Unleash the Tabletsover 21 years ago
Eisai's New Leadershipover 21 years ago
Superstar Selectionover 21 years ago
TOCover 21 years ago
Professional Persuasion:101





